247 related articles for article (PubMed ID: 8798974)
1. AIDS patient monocytes target CD4 T cells for cellular conjugate formation and deletion through the membrane expression of HIV-1 envelope molecules.
Dudhane A; Wang ZQ; Orlikowsky T; Gupta A; Wormser GP; Horowitz H; Kufer P; Hoffmann MK
AIDS Res Hum Retroviruses; 1996 Jul; 12(10):893-9. PubMed ID: 8798974
[TBL] [Abstract][Full Text] [Related]
2. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients.
Amadori A; De Silvestro G; Zamarchi R; Veronese ML; Mazza MR; Schiavo G; Panozzo M; De Rossi A; Ometto L; Mous J
J Immunol; 1992 May; 148(9):2709-16. PubMed ID: 1374095
[TBL] [Abstract][Full Text] [Related]
3. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.
Chien PC; Chen D; Chen PD; Tuen M; Cohen S; Migueles SA; Connors M; Rosenberg E; Malhotra U; Gonzalez C; Hioe CE
J Infect Dis; 2004 Mar; 189(5):852-61. PubMed ID: 14976603
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120.
Hioe CE; Tuen M; Chien PC; Jones G; Ratto-Kim S; Norris PJ; Moretto WJ; Nixon DF; Gorny MK; Zolla-Pazner S
J Virol; 2001 Nov; 75(22):10950-7. PubMed ID: 11602735
[TBL] [Abstract][Full Text] [Related]
5. Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity.
Dudhane A; Conti B; Orlikowsky T; Wang ZQ; Mangla N; Gupta A; Wormser GP; Hoffmann MK
AIDS Res Hum Retroviruses; 1996 Jul; 12(10):885-92. PubMed ID: 8798973
[TBL] [Abstract][Full Text] [Related]
6. A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages.
Dimitrov DS; Norwood D; Stantchev TS; Feng Y; Xiao X; Broder CC
Virology; 1999 Jun; 259(1):1-6. PubMed ID: 10364484
[TBL] [Abstract][Full Text] [Related]
7. Detection of T cell CD4 epitopes in HIV-infected individuals.
Kunkl A; Valle MT; Fenoglio D; Dodi F; Morandi N; Rizzo F; Manca F
Eur J Histochem; 1994; 38 Suppl 1():41-6. PubMed ID: 8547709
[TBL] [Abstract][Full Text] [Related]
8. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects.
Cohen S; Tuen M; Hioe CE
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):793-806. PubMed ID: 14585210
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone inhibits CD4 T cell deletion mediated by macrophages from human immunodeficiency virus-infected persons.
Orlikowsky TW; Wang ZQ; Dudhane A; Dannecker GE; Niethammer D; Wormser GP; Hoffmann MK; Horowitz HW
J Infect Dis; 2001 Nov; 184(10):1328-30. PubMed ID: 11679924
[TBL] [Abstract][Full Text] [Related]
10. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients.
Wang ZQ; Orlikowsky T; Dudhane A; Mittler R; Blum M; Lacy E; Riethmüller G; Hoffmann MK
Eur J Immunol; 1994 Jul; 24(7):1553-7. PubMed ID: 7913036
[TBL] [Abstract][Full Text] [Related]
11. The orientation of HIV-1 gp120 binding to the CD4 receptor differentially modulates CD4+ T cell activation.
Zimmermann K; Liechti T; Haas A; Rehr M; Trkola A; Günthard HF; Oxenius A
J Immunol; 2015 Jan; 194(2):637-49. PubMed ID: 25472996
[TBL] [Abstract][Full Text] [Related]
12. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
Ahmad A; Ladha A; Cohen EA; Menezes J
Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
[TBL] [Abstract][Full Text] [Related]
13. Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells.
Crowe SM; Mills J; Kirihara J; Boothman J; Marshall JA; McGrath MS
AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1031-7. PubMed ID: 1977427
[TBL] [Abstract][Full Text] [Related]
14. CD4+ lymphocyte function with early human immunodeficiency virus infection.
Gurley RJ; Ikeuchi K; Byrn RA; Anderson K; Groopman JE
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1993-7. PubMed ID: 2564677
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HSV-1-specific cytotoxic T lymphocytes by recombinant-derived gp120 of HIV-1.
Schmid DS; Thieme ML; Ridgeway MR; Mawle AC
Viral Immunol; 1992; 5(4):249-56. PubMed ID: 1361737
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the basis of resistance and susceptibility of CD4+ T cells to human immunodeficiency virus (HIV)-gp120 induced anergy.
Faith A; O'Hehir RE; Malkovsky M; Lamb JR
Immunology; 1992 Jun; 76(2):177-84. PubMed ID: 1353060
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic monocytes in the blood of HIV type 1-infected subjects destroy targeted T cells in a CD95-dependent fashion.
Orlikowsky T; Wang ZQ; Dudhane A; Horowitz H; Riethmuller G; Hoffmann MK
AIDS Res Hum Retroviruses; 1997 Jul; 13(11):953-60. PubMed ID: 9223411
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation.
Wang JM; Ueda H; Howard OM; Grimm MC; Chertov O; Gong X; Gong W; Resau JH; Broder CC; Evans G; Arthur LO; Ruscetti FW; Oppenheim JJ
J Immunol; 1998 Oct; 161(8):4309-17. PubMed ID: 9780207
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus grown in CD4-expressing cells is associated with CD4.
Hartley CA; Gilbert MJ; Brigido L; Elbeik T; Levy JA; Crowe SM; Mills J
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2015-23. PubMed ID: 8810998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
